LASIK Eye Surgery: Global Market Research and Forecast 2018-2023 -

DUBLIN--()--The "Global LASIK Eye Surgery Market Research and Forecast 2018-2023" report has been added to's offering.

The LASIK eye surgery market is expected to grow significantly during the forecast period (2018-2023).

The global eye surgery market has been growing significantly due to various factors such as technological advancement and innovations. Rising awareness among people is one of the major reasons for the growth of this market. Increasing vision defects due to pollution, consistent use of computers and mobile phones, atmosphere and so on creates demand for eye surgeries across the globe.

This surgery is considered to be effective due to various aspects such as fast recovery time, high precision, shorter hospital stays and less blood loss. Growing health concern among the people across the globe and rising disposable income will further boost the market growth. However, there are some factors acting as barrier for this market which includes high price of the treatment and unfavorable reimbursement policies.

Asia Pacific which includes India, Japan and China are considered to be the fastest growing LASIK eye surgery market due to rapid developing healthcare technologies and significant pool of eye patients. North America dominates the whole market due to development of innovative technologies, highest healthcare spending and growing awareness. Europe covers considerable market share due to cohesive government policies and funds for R&D to explore eye care treatment.

The companies contributing in the global market includes Alcon, Bausch&Lomb, and Novartis, Allergan, Topcon cooperation and Johnson&Johnson. The companies are offering innovative products and equipment for better eye care. The companies are focusing on product launch, merger and acquisition, collaboration and partnerships and geographical expansion to stay competitive.

For an instance; The LASIK Vision Institute in February 2018 opened a center in Duluth, Georgia. The center will have the latest in FDA-approved technology, topography-guided LASIK technology.

Key Topics Covered

1. Report Summary

1.1. Research Methods And Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

1.2.3. By Stakeholders

2. Market Overview And Insights

2.1. Definition

2.2. Analyst Insights &Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendation

2.2.3. Conclusion

2.3. Regulations

2.3.1. United States

2.3.2. European Union

2.3.3. China

2.3.4. India

2.3.5. Rest Of The World

3. Market Determinants

3.1. Drivers

3.1.1. Technological Advancement in Laser Eye Surgery Market

3.1.2. Growing Incidence and Prevalence of Eye Diseases

3.1.3. Rising Demand for Minimally Invasive Surgeries

3.1.4. Faster Recovery and High Precision

3.2. Restraints

3.2.1. High Price of Treatment

3.2.2. Unfavourable Reimbursement Policies

3.3. Opportunities

3.3.1. Government Support and Funded Initiatives

3.3.2. Increasing Awareness of Lasik Surgery Across the Globe

4. Market Segmentation

4.1. By Of Vision Error

4.1.1. Myopia

4.1.2. Hyperopia

4.1.3. Astigmatism

4.2. By End User

4.2.1. Hospitals

4.2.2. Eye Care Clinic And Lasik Centres

4.3. By Type

4.3.1. Wavefront Optimized

4.3.2. Wavefront-Guided

4.3.3. Topography Guided

5. Competitive Landscape

5.1. Key Market Strategies

5.2. Key Company Analysis

6. Regional Analysis

6.1. North America

6.2. Europe

6.3. Asia Pacific

6.4. Rest Of The World

7. Company Profiles

7.1. Abbott Laboratories Inc.

7.2. Accutome Inc.

7.3. Alcon Laboratories Inc.

7.4. Allergan PLC

7.5. Auro Laboratories Limited

7.6. Bausch & Lomb Incorporated

7.7. Biotech Vision Care Pvt. Ltd.

7.8. Carl Zeiss AG

7.9. Ciba Vision

7.10. Coopervision Inc.

7.11. Essilor International S.A.

7.12. Hoya Corporation

7.13. Johnson & Johnson

7.14. Laser Sight Technologies Inc.

7.15. Luxottica Group S.P.A.

7.16. Nidek Corporation

7.17. Novartis International AG

7.18. The Lasik Vision Institute LLC

7.19. The Omaha Eye & Laser Institute

7.20. Topcon Corporation

7.21. Valeant Pharmaceuticals International Inc.

7.22. Visufarma B.V.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical , Surgical Procedures

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Optical , Surgical Procedures